AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29234853 — intervention group
Group type: EXPERIMENTAL
Intervention: In Situ Septoplasty
Number of subjects: 0
Study 29234853 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Subtotal Septal Reconstruction
Number of subjects: 0
Study 29234853 — intervention group
Group type: COMPARATOR
Intervention: Control (Self-Controlled)
Number of subjects: 0
Study 27009022 — intervention group
Group type: EXPERIMENTAL
Intervention: ixmyelocel‐T
Number of subjects: 114
Study 27009022 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle control)
Number of subjects: 114
Study 24169365 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleaved Combination Method (ICM)
Number of subjects: 14
Study 24169365 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconditioning Combination Method (PCM)
Number of subjects: 14
Study 24169365 — intervention group
Group type: EXPERIMENTAL
Intervention: ICM and PCM
Number of subjects: 14
Study 22327806 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored video promoting positive attitudes toward mammography
Number of subjects: 592
Study 22327806 — intervention group
Group type: COMPARATOR
Intervention: Linguistically appropriate generic video
Number of subjects: 592
Study 22327806 — intervention group
Group type: COMPARATOR
Intervention: Print media
Number of subjects: 592
Study 20639825 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Appendectomy (LA)
Number of subjects: 60
Study 20639825 — intervention group
Group type: COMPARATOR
Intervention: Open Appendectomy (OA)
Number of subjects: 60
Study 17110413 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins C (2 g) and E (400 IU) given 2 h before a second dive
Number of subjects: 7
Study 17110413 — intervention group
Group type: COMPARATOR
Intervention: Placebo (pre-dive)
Number of subjects: 7
Study 19260170 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehband cooling garment
Number of subjects: 43
Study 19260170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 15288288 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered Ultraflex stent placement
Number of subjects: 209
Study 15288288 — intervention group
Group type: COMPARATOR
Intervention: Single dose (12 Gy) brachytherapy
Number of subjects: 209
Study 10983672 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 10
Study 10983672 — intervention group
Group type: COMPARATOR
Intervention: MRI
Number of subjects: 10
Study 8782752 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted-dose warfarin (INR 2.0-3.0)
Number of subjects: 1044
Study 8782752 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity, fixed-dose warfarin (INR 1.2-1.5) plus aspirin (325 mg/day)
Number of subjects: 1044
Study 1381070 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient pain management programme
Number of subjects: 52
Study 1381070 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient pain management programme
Number of subjects: 52
Study 1381070 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 6654697 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Jamaican government school meal
Number of subjects: 0
Study 30632640 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI‐KIDS multicomponent physical activity intervention (three weekly after‐school sessions of recreational non‐competitive PA lasting 60 minutes during one academic year, educational materials for parents and teachers, school playground modifications)
Number of subjects: 240
Study 30632640 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 240
Study 28988172 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 220
Study 28988172 — intervention group
Group type: COMPARATOR
Intervention: Colloids
Number of subjects: 220
Study 25209658 — intervention group
Group type: EXPERIMENTAL
Intervention: Food advertising
Number of subjects: 0
Study 23819955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, home-based intervention (HBI)
Number of subjects: 602
Study 23819955 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 602
Study 22087062 — intervention group
Group type: EXPERIMENTAL
Intervention: Doloraz(®) (100 mg ibuprofen/5 mL suspension)
Number of subjects: 24
Study 22087062 — intervention group
Group type: COMPARATOR
Intervention: Brufen(®) (100 mg ibuprofen/5 mL suspension)
Number of subjects: 24
Study 18372254 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH-only preparations following a low-dose step-up protocol
Number of subjects: 151
Study 18372254 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 151
Study 16448799 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care for depressive symptoms
Number of subjects: 62
Study 16448799 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem solving training
Number of subjects: 62
Study 16448799 — intervention group
Group type: COMPARATOR
Intervention: Nursing care
Number of subjects: 62
Study 12850192 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 gene therapy in combination with standard chemotherapy
Number of subjects: 0
Study 12850192 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 0
Study 10653081 — intervention group
Group type: EXPERIMENTAL
Intervention: Total shoulder arthroplasty
Number of subjects: 47
Study 10653081 — intervention group
Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 47
Study 8990505 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical R-85355
Number of subjects: 11
Study 8990505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1473919 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopamidol administered intra-arterially
Number of subjects: 61
Study 1473919 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol administered intravenously
Number of subjects: 61
Study 1473919 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioxaglate administered intra-arterially
Number of subjects: 61
Study 1473919 — intervention group
Group type: COMPARATOR
Intervention: Ioxaglate administered intravenously
Number of subjects: 61
Study 6383612 — intervention group
Group type: EXPERIMENTAL
Intervention: 500-mg tablet of clotrimazole
Number of subjects: 26
Study 6383612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 31764454 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) with high-density EEG recording
Number of subjects: 5
Study 27913989 — intervention group
Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 0
Study 27913989 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 0
Study 27120329 — intervention group
Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT)
Number of subjects: 18
Study 27120329 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical management
Number of subjects: 18
Study 24477835 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation (5 g day(‐1) of powdered 1:0.5:0.5 leucine:isoleucine:valine)
Number of subjects: 46
Study 24477835 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation
Number of subjects: 46
Study 23134831 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% gelofusine, crystal/gel ratio 0:1
Number of subjects: 32
Study 23134831 — intervention group
Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch and sodium chloride injection, crystal/gel ratio 1:1
Number of subjects: 32
Study 20370963 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine or bupropion added to mood stabilizers
Number of subjects: 4361
Study 20370963 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychosocial interventions
Number of subjects: 4361
Study 20370963 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine, risperidone, or inositol
Number of subjects: 4361
Study 17662528 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaided smoking cessation (2 months)
Number of subjects: 20
Study 17662528 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers (control group)
Number of subjects: 20
Study 16305705 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% oxygen partial pressure (n = 65)
Number of subjects: 225
Study 16305705 — intervention group
Group type: COMPARATOR
Intervention: 20% oxygen partial pressure (n = 61)
Number of subjects: 225
Study 11468025 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) using Bayesian methodology
Number of subjects: 236
Study 11468025 — intervention group
Group type: COMPARATOR
Intervention: Loading dose (LD) of 25 mg/kg body weight
Number of subjects: 236
Study 11468025 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated dose (CD)
Number of subjects: 236
Study 11468025 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) in ventilated patients
Number of subjects: 236
Study 11468025 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated dose (CD) in patients with SAPS > 35
Number of subjects: 236
Study 9706734 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) adjunctive therapy
Number of subjects: 0
Study 8156738 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (10 ng min‐1 100 ml‐1 forearm volume)
Number of subjects: 10
Study 8156738 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (equipotent vasodilator dose)
Number of subjects: 10
Study 8156738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3279775 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg per day of ketoconazole
Number of subjects: 112
Study 3279775 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg per day of ketoconazole
Number of subjects: 112
Study 3279775 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,200 or 1,600 mg per day of ketoconazole
Number of subjects: 112
Study 3279775 — intervention group
Group type: EXPERIMENTAL
Intervention: higher than 400 mg dosages
Number of subjects: 112
Study 30120313 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 171
Study 30120313 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with a behavioural approach (NSEB)
Number of subjects: 171
Study 30120313 — intervention group
Group type: COMPARATOR
Intervention: Prescription of physical activity (PPA)
Number of subjects: 171
Study 28746228 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated B‐lines of hand ultrasound with a wet foam dressing material (SG)
Number of subjects: 150
Study 28746228 — intervention group
Group type: COMPARATOR
Intervention: Real video clips of B‐lines (RG)
Number of subjects: 150
Study 25791373 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling by pharmacists
Number of subjects: 211
Study 25791373 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 211
Study 24279445 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 16492
Study 24279445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16492
Study 21167338 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1000
Study 21167338 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (MED)
Number of subjects: 1000
Study 18342223 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg the day before (>or=15 h) and 600 mg the morning of the procedure (>or=2 h) (Group C)
Number of subjects: 148
Study 18342223 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 300 mg the day before (>or=15 h) + 75 mg the morning of the procedure (Group A)
Number of subjects: 148
Study 18342223 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 600 mg the morning of the procedure (>or=2 h) (Group B)
Number of subjects: 148
Study 16552626 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT)
Number of subjects: 20
Study 16552626 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 20
Study 12651677 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural neostigmine (4 microg/kg) combined with ropivacaine 0.1%
Number of subjects: 0
Study 12651677 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural neostigmine (4 microg/kg) combined with ropivacaine 0.1% and sufentanil 10 microg
Number of subjects: 0
Study 12651677 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia with ropivacaine 0.1%
Number of subjects: 0
Study 10881260 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhancement of low, middle, or high facial frequency information (cycles per face) through presentation of photographs of unfamiliar faces.
Number of subjects: 0
Study 10881260 — intervention group
Group type: EXPERIMENTAL
Intervention: Low facial frequency information (cycles per face)
Number of subjects: 0
Study 9255192 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) with conventional ventilation
Number of subjects: 205
Study 9255192 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 205
Study 9255192 — intervention group
Group type: COMPARATOR
Intervention: Crossover treatment with iNO after HFOV failure
Number of subjects: 205
Study 9255192 — intervention group
Group type: COMPARATOR
Intervention: Crossover treatment with HFOV after iNO failure
Number of subjects: 205
Study 9255192 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with HFOV plus iNO
Number of subjects: 205
Study 9255192 — intervention group
Group type: EXPERIMENTAL
Intervention: Either treatment alone or combination therapy
Number of subjects: 205
Study 9255192 — intervention group
Group type: EXPERIMENTAL
Intervention: HFOV plus iNO in respiratory distress syndrome and meconium aspiration syndrome
Number of subjects: 205
Study 9255192 — intervention group
Group type: COMPARATOR
Intervention: Overall outcomes across centers
Number of subjects: 205
Study 8509981 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (Protocol 019)
Number of subjects: 73
Study 8509981 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 73
Study 8509981 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol 019
Number of subjects: 73
Study 8509981 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 73
Study 3625231 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous therapy with murine antimelanoma monoclonal antibody 9.2.27, 500 mg dose
Number of subjects: 13
Study 3625231 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 2 h infusion of 500 mg of 9.2.27
Number of subjects: 13
Study 3625231 — intervention group
Group type: EXPERIMENTAL
Intervention: Five daily 2 h infusions of 100 mg of 9.2.27
Number of subjects: 13
Study 3625231 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruption in therapy for 4 weeks
Number of subjects: 13
Study 3625231 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial infusions of 500 mg of 9.2.27
Number of subjects: 13
Study 3625231 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring antiglobulin levels during therapy
Number of subjects: 13
Study 31974286 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.5 meq/kg lean body wt per day; n=35)
Number of subjects: 74
Study 31974286 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=39)
Number of subjects: 74
Study 31547827 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine
Number of subjects: 0
Study 31547827 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0
Study 31547827 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine
Number of subjects: 0
Study 31547827 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine (0.5 mg/kg/day for 7-9 days)
Number of subjects: 0
Study 28962948 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT) with thoracic radiotherapy (50 Gy in 25 fractions) and five cycles of weekly paclitaxel (50 mg/m2) and cisplatin (25 mg/m2), followed by two additional cycles of paclitaxel (175 mg/m2) plus cisplatin (80 mg/m2) at 3-week intervals.
Number of subjects: 101
Study 28962948 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with four cycles of adjuvant paclitaxel (175 mg/m2) and carboplatin (AUC = 5.5) every 3 weeks.
Number of subjects: 101
Study 28962948 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT
Number of subjects: 101
Study 28962948 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 101
Study 25712944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic blood pressure <140 mm Hg)
Number of subjects: 1310
Study 25712944 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (systolic blood pressure <180 mm Hg)
Number of subjects: 1310
Study 23231426 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 858
Study 23231426 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 858
Study 21390165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 20 µg
Number of subjects: 72
Study 21390165 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 2.5 µg
Number of subjects: 72
Study 21390165 — intervention group
Group type: COMPARATOR
Intervention: Control (0.5% hyperbaric bupivacaine only)
Number of subjects: 72
Study 20032609 — intervention group
Group type: EXPERIMENTAL
Intervention: Bethanechol administration during radiotherapy
Number of subjects: 36
Study 20032609 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva (control)
Number of subjects: 36
Study 18693589 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC‐40) 40 mg instilled within 30 minutes of TUR
Number of subjects: 75
Study 18693589 — intervention group
Group type: COMPARATOR
Intervention: Control group (TUR only)
Number of subjects: 75
Study 15010178 — intervention group
Group type: EXPERIMENTAL
Intervention: Consume MSG+
Number of subjects: 113
Study 15010178 — intervention group
Group type: COMPARATOR
Intervention: Consume MSG‐
Number of subjects: 113
Study 15010178 — intervention group
Group type: COMPARATOR
Intervention: Taste MSG+
Number of subjects: 113
Study 12530552 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 33
Study 12530552 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 33
Study 12530552 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil
Number of subjects: 33
Study 9440666 — intervention group
Group type: EXPERIMENTAL
Intervention: Olestra potato chips
Number of subjects: 1123
Study 9440666 — intervention group
Group type: COMPARATOR
Intervention: Regular TG potato chips
Number of subjects: 1123
Study 7532056 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 42
Study 7532056 — intervention group
Group type: COMPARATOR
Intervention: Control group (no G-CSF)
Number of subjects: 42
Study 2547916 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil containing eicosapentaenoic acid and docosahexaenoic acid
Number of subjects: 0
Study 2547916 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil treatment
Number of subjects: 0
Study 1093633 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole nitrate
Number of subjects: 69
Study 1093633 — intervention group
Group type: COMPARATOR
Intervention: Chlordantoin
Number of subjects: 69
Study 1093633 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole nitrate (after second course)
Number of subjects: 69
Study 1093633 — intervention group
Group type: COMPARATOR
Intervention: Chlordantoin (after second course)
Number of subjects: 69
Study 310412 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrozepin therapy
Number of subjects: 0
Study 310412 — intervention group
Group type: COMPARATOR
Intervention: Indometacin
Number of subjects: 0
Study 31006545 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Ultrabiotic 60™ and SB Floractiv™ 250 mg)
Number of subjects: 19
Study 31006545 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 19
Study 31006545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 28125624 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 90
Study 28125624 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 90
Study 25601978 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat antenatal betamethasone
Number of subjects: 258
Study 25601978 — intervention group
Group type: COMPARATOR
Intervention: Placebo (single course)
Number of subjects: 258
Study 23699515 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-pulse transcranial magnetic stimulation (dpTMS) during resting state
Number of subjects: 64
Study 23699515 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-pulse transcranial magnetic stimulation (dpTMS) during event-related condition
Number of subjects: 64
Study 23699515 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-pulse transcranial magnetic stimulation (dpTMS)
Number of subjects: 64
Study 21366974 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative whole breast irradiation (RT)
Number of subjects: 0
Study 21366974 — intervention group
Group type: COMPARATOR
Intervention: Omission of RT
Number of subjects: 0
Study 19336728 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg/wk
Number of subjects: 80
Study 19336728 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 100 mg/wk
Number of subjects: 80
Study 19336728 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 80
Study 19336728 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide (both doses)
Number of subjects: 80
Study 17899572 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone vaginal gel
Number of subjects: 659
Study 17899572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 659
Study 15514398 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 27
Study 15514398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11916619 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-soak group (gentamicin solution for approximately 2 min)
Number of subjects: 186